U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H18F3NO.ClH
Molecular Weight 321.766
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LANPERISONE HYDROCHLORIDE

SMILES

Cl.C[C@H](CN1CCCC1)C(=O)C2=CC=C(C=C2)C(F)(F)F

InChI

InChIKey=PHBZFPOOJUGYCR-RFVHGSKJSA-N
InChI=1S/C15H18F3NO.ClH/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18;/h4-7,11H,2-3,8-10H2,1H3;1H/t11-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C15H18F3NO
Molecular Weight 285.3047
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Lanperisone (NK433) is muscle relaxant. It acts by blocking voltage-gated sodium channels.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
13.7 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
In studies of muscle relaxation effect on rats and cats, NK433 was administered either parenterally via a cannula previously inserted into the jugular, cephalic or femoral vein. In oral administration study, NK433 was dissolved in distilled water and was administered via a cannula previously inserted into the stomach. NK433 reduced the mono- and polysynaptic reflex potential at doses of 5 and 10 mg/kg, i.v.
Route of Administration: Other
In Vitro Use Guide
Binding to Voltage-gated sodium channels was studied using [3H]batrachotoxinin A 20-alpha-benzoate ([3H]-BTX) assay with rat cerebrocortical synaptosomes. Aliquots (100 μL) equal to approximately 6 to 8 mg/ml protein were used in [3H]BTX binding experiments. Binding assays were performed in the presence of 5.0 nM [3H]BTX, 1 μΜ tetrodotoxin, 4.0 μg of scorpion toxin, and various concentrations of the added drugs at 37°C for 60-min incubation time. Nonspecific binding was determined in the presence of 300 μΜ aconitine. The reaction was terminated by rapid filtration using a UniFilter-96 GF/B (PerkinElmer Life and Analytical Sciences). The filtration plates were washed five times with ice-cold wash buffer. Radioactivity trapped on a 96-well filtration plate was measured by liquid scintillation spectrometry in 40 μL of Mi-croscint 20 scintillation cocktail. Binding affinity of lanperisone was determined to be 13.7 uM.
Substance Class Chemical
Record UNII
JRF22NV56M
Record Status Validated (UNII)
Record Version